Kluft C, Michiels J J, Wijngaards G
Scand J Haematol. 1980 Nov;25(5):423-30. doi: 10.1111/j.1600-0609.1981.tb01424.x.
3 patients with Behçet's disease were studied for their fibrinolytic status during exacerbation of the disease accompanied with thrombotic complications. All 3 patients exhibited low euglobulin fibrinolytic activity. This, however, could be attributed to an artificially increased coprecipitation of inhibitors, i.e., C1-inactivator in the euglobulin fractions. This phenomenon correlated with and was possibly related to inflammatory reactions in the patients. The most severely diseased patient only showed an increased plasmin inhibition in the plasma and a decreased response to venous occlusion. The increased plasmin inhibition was due to a slow type of inhibition, which could not be attributed to known protease inhibitors in blood. Its physiological relevance to fibrinolysis is questionable. There was no evidence for relevant general deviations in the fibrinolytic system in Behçet's disease; only for the severe case may the decreased fibrinolytic potency revealed by venous occlusion have contributed to the extent of the thrombotic manifestations.
对3例伴有血栓形成并发症的白塞病加重期患者的纤溶状态进行了研究。所有3例患者均表现出低优球蛋白纤溶活性。然而,这可能归因于抑制剂(即优球蛋白组分中的C1灭活剂)人为增加的共沉淀。这种现象与患者的炎症反应相关且可能有关。病情最严重的患者仅表现出血浆中纤溶酶抑制增加以及对静脉闭塞的反应降低。纤溶酶抑制增加是由于一种缓慢的抑制类型,这不能归因于血液中已知的蛋白酶抑制剂。其与纤维蛋白溶解的生理相关性值得怀疑。没有证据表明白塞病的纤溶系统存在相关的一般偏差;仅对于严重病例,静脉闭塞显示的纤溶能力降低可能导致了血栓形成表现的程度。